These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26969274)

  • 21. GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy.
    Miyata H; Hirohashi Y; Yamada S; Yanagawa J; Murai A; Hashimoto S; Tokita S; Hori K; Abe T; Kubo T; Tsukahara T; Kanaseki T; Shinohara N; Torigoe T
    Cancer Immunol Immunother; 2022 Apr; 71(4):795-806. PubMed ID: 34405274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasticity of lung cancer stem-like cells is regulated by the transcription factor HOXA5 that is induced by oxidative stress.
    Saijo H; Hirohashi Y; Torigoe T; Horibe R; Takaya A; Murai A; Kubo T; Kajiwara T; Tanaka T; Shionoya Y; Yamamoto E; Maruyama R; Nakatsugawa M; Kanaseki T; Tsukahara T; Tamura Y; Sasaki Y; Tokino T; Suzuki H; Kondo T; Takahashi H; Sato N
    Oncotarget; 2016 Aug; 7(31):50043-50056. PubMed ID: 27418136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Olfactory Receptor Family 7 Subfamily C Member 1 Is a Novel Marker of Colon Cancer-Initiating Cells and Is a Potent Target of Immunotherapy.
    Morita R; Hirohashi Y; Torigoe T; Ito-Inoda S; Takahashi A; Mariya T; Asanuma H; Tamura Y; Tsukahara T; Kanaseki T; Kubo T; Kutomi G; Mizuguchi T; Terui T; Ishitani K; Hashino S; Kondo T; Minagawa N; Takahashi N; Taketomi A; Todo S; Asaka M; Sato N
    Clin Cancer Res; 2016 Jul; 22(13):3298-309. PubMed ID: 26861454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene expression profiles of prostate cancer stem cells isolated by aldehyde dehydrogenase activity assay.
    Nishida S; Hirohashi Y; Torigoe T; Kitamura H; Takahashi A; Masumori N; Tsukamoto T; Sato N
    J Urol; 2012 Jul; 188(1):294-9. PubMed ID: 22608744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radioresistance of cancer stem-like cell derived from canine tumours.
    Tanabe A; Deguchi T; Sato T; Nemoto Y; Maruo T; Madarame H; Shida T; Naya Y; Ogihara K; Sahara H
    Vet Comp Oncol; 2016 Sep; 14(3):e93-e101. PubMed ID: 25070729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential regulation of the sphere formation and maintenance of cancer-initiating cells of malignant mesothelioma via CD44 and ALK4 signaling pathways.
    Ohno Y; Shingyoku S; Miyake S; Tanaka A; Fudesaka S; Shimizu Y; Yoshifuji A; Yamawaki Y; Yoshida S; Tanaka S; Sakura K; Tanaka T
    Oncogene; 2018 Dec; 37(49):6357-6367. PubMed ID: 30061637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficiency of G2/M-related tumor-associated antigen-targeting cancer immunotherapy depends on antigen expression in the cancer stem-like population.
    Mori T; Nishizawa S; Hirohashi Y; Torigoe T; Tamura Y; Takahashi A; Kochin V; Fujii R; Kondo T; Greene MI; Hara I; Sato N
    Exp Mol Pathol; 2012 Feb; 92(1):27-32. PubMed ID: 22001602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preferential expression of cancer/testis genes in cancer stem-like cells: proposal of a novel sub-category, cancer/testis/stem gene.
    Yamada R; Takahashi A; Torigoe T; Morita R; Tamura Y; Tsukahara T; Kanaseki T; Kubo T; Watarai K; Kondo T; Hirohashi Y; Sato N
    Tissue Antigens; 2013 Jun; 81(6):428-34. PubMed ID: 23574628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis.
    Marcato P; Dean CA; Pan D; Araslanova R; Gillis M; Joshi M; Helyer L; Pan L; Leidal A; Gujar S; Giacomantonio CA; Lee PW
    Stem Cells; 2011 Jan; 29(1):32-45. PubMed ID: 21280157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CXC chemokine receptor 4 is essential for maintenance of renal cell carcinoma-initiating cells and predicts metastasis.
    Gassenmaier M; Chen D; Buchner A; Henkel L; Schiemann M; Mack B; Schendel DJ; Zimmermann W; Pohla H
    Stem Cells; 2013 Aug; 31(8):1467-76. PubMed ID: 23630186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acquisition of tumorigenic potential and enhancement of angiogenesis in pulmonary stem/progenitor cells through Oct-4 hyperexpression.
    Gu SY; Ho CC; Huang YK; Chen HW; Wang YC; Kuo CY; Teng SC; Fu WM; Yang PC; Wu CW; Peng FC; Ling TY
    Oncotarget; 2016 Mar; 7(12):13917-31. PubMed ID: 26871601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropilin-1 is expressed by breast cancer stem-like cells and is linked to NF-κB activation and tumor sphere formation.
    Glinka Y; Mohammed N; Subramaniam V; Jothy S; Prud'homme GJ
    Biochem Biophys Res Commun; 2012 Sep; 425(4):775-80. PubMed ID: 22885184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. STAT3 signaling is activated preferentially in tumor-initiating cells in claudin-low models of human breast cancer.
    Wei W; Tweardy DJ; Zhang M; Zhang X; Landua J; Petrovic I; Bu W; Roarty K; Hilsenbeck SG; Rosen JM; Lewis MT
    Stem Cells; 2014 Oct; 32(10):2571-82. PubMed ID: 24891218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ATOH1 Can Regulate the Tumorigenicity of Gastric Cancer Cells by Inducing the Differentiation of Cancer Stem Cells.
    Han ME; Baek SJ; Kim SY; Kang CD; Oh SO
    PLoS One; 2015; 10(5):e0126085. PubMed ID: 25950549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunomodulating and Immunoresistance Properties of Cancer-Initiating Cells: Implications for the Clinical Success of Immunotherapy.
    Maccalli C; Parmiani G; Ferrone S
    Immunol Invest; 2017 Apr; 46(3):221-238. PubMed ID: 28287848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lunasin is a novel therapeutic agent for targeting melanoma cancer stem cells.
    Shidal C; Al-Rayyan N; Yaddanapudi K; Davis KR
    Oncotarget; 2016 Dec; 7(51):84128-84141. PubMed ID: 27566591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of cancer stem cells in the modulation of anti-tumor immune responses.
    Maccalli C; Rasul KI; Elawad M; Ferrone S
    Semin Cancer Biol; 2018 Dec; 53():189-200. PubMed ID: 30261276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting USP22 Suppresses Tumorigenicity and Enhances Cisplatin Sensitivity Through ALDH1A3 Downregulation in Cancer-Initiating Cells from Lung Adenocarcinoma.
    Yun X; Zhang K; Wang J; Pangeni RP; Yang L; Bonner M; Wu J; Wang J; Nardi IK; Gao M; Raz DJ
    Mol Cancer Res; 2018 Jul; 16(7):1161-1171. PubMed ID: 29720480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ALDH activity indicates increased tumorigenic cells, but not cancer stem cells, in prostate cancer cell lines.
    Yu C; Yao Z; Dai J; Zhang H; Escara-Wilke J; Zhang X; Keller ET
    In Vivo; 2011; 25(1):69-76. PubMed ID: 21282737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LGR5-positive colon cancer stem cells interconvert with drug-resistant LGR5-negative cells and are capable of tumor reconstitution.
    Kobayashi S; Yamada-Okabe H; Suzuki M; Natori O; Kato A; Matsubara K; Jau Chen Y; Yamazaki M; Funahashi S; Yoshida K; Hashimoto E; Watanabe Y; Mutoh H; Ashihara M; Kato C; Watanabe T; Yoshikubo T; Tamaoki N; Ochiya T; Kuroda M; Levine AJ; Yamazaki T
    Stem Cells; 2012 Dec; 30(12):2631-44. PubMed ID: 23081779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.